Editas Medicine, Inc.

NasdaqGS:EDIT Stock Report

Market Cap: US$258.4m

Editas Medicine Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:EDIT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
03 Mar 26SellUS$957Amy ParisonIndividual474US$2.02
03 Dec 25SellUS$993Amy ParisonIndividual461US$2.15
03 Dec 25SellUS$12,064Gilmore O’NeillIndividual5,603US$2.15
03 Dec 25SellUS$1,535Linda BurklyIndividual713US$2.15
03 Sep 25SellUS$1,189Amy ParisonIndividual458US$2.60
03 Sep 25SellUS$14,517Gilmore O’NeillIndividual5,592US$2.60
03 Sep 25SellUS$1,843Linda BurklyIndividual710US$2.60
07 Aug 25SellUS$1,752Amy ParisonIndividual679US$2.58
31 Jul 25SellUS$12,757Linda BurklyIndividual5,121US$2.49
03 Jun 25SellUS$26,196Gilmore O’NeillIndividual15,192US$1.72
03 Jun 25SellUS$1,252Linda BurklyIndividual726US$1.72
03 Jun 25SellUS$769Amy ParisonIndividual446US$1.72

Insider Trading Volume

Insider Buying: EDIT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of EDIT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders354,0290.363%
General Public46,426,93047.6%
Institutions50,837,70152.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18%.

Top Shareholders

Top 25 shareholders own 44.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.58%
BlackRock, Inc.
9,347,114US$24.7m16.6%no data
8.41%
The Vanguard Group, Inc.
8,208,068US$21.7m17.8%no data
3.11%
Renaissance Technologies LLC
3,039,778US$8.0m138%0.01%
2.34%
Geode Capital Management, LLC
2,284,740US$6.0m12%no data
2.02%
State Street Global Advisors, Inc.
1,974,931US$5.2m2.59%no data
1.95%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,902,709US$5.0m-3.95%no data
1.67%
Two Sigma Investments, LP
1,632,584US$4.3m3.06%0.01%
1.25%
Two Sigma Advisers, LP
1,224,100US$3.2m1.59%0.01%
1.21%
Raymond James Financial, Inc.
1,184,670US$3.1m623%no data
1.21%
Jane Street Group, LLC
1,176,580US$3.1m128%no data
1.14%
D. E. Shaw & Co., L.P.
1,109,590US$2.9m855%no data
0.97%
Susquehanna International Group, LLP
949,017US$2.5m-14.3%no data
0.85%
Jacobs Levy Equity Management Inc
827,140US$2.2m3.39%0.01%
0.84%
Citadel Advisors LLC
820,993US$2.2m127%no data
0.83%
UBS Asset Management AG
809,342US$2.1m91.6%no data
0.82%
Acadian Asset Management LLC
799,847US$2.1m124%no data
0.81%
Charles Schwab Investment Management, Inc.
794,671US$2.1m1.89%no data
0.75%
Point72 Asset Management, L.P.
733,483US$1.9m144%no data
0.72%
JP Morgan Asset Management
702,716US$1.9m8.08%no data
0.68%
The Goldman Sachs Group, Inc.
665,248US$1.8m221%no data
0.68%
Northern Trust Global Investments
662,459US$1.8m-1.08%no data
0.64%
AQR Capital Management, LLC
623,820US$1.7m-6.48%no data
0.63%
Morgan Stanley
616,386US$1.6m-40.2%no data
0.58%
GSA Capital Partners LLP
568,809US$1.5m0%0.12%
0.58%
Kennedy Capital Management LLC
562,140US$1.5m-0.62%0.03%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/03/11 08:44
End of Day Share Price 2026/03/11 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Editas Medicine, Inc. is covered by 25 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jack AllenBaird
Joel BeattyBaird
Alec StranahanBofA Global Research